Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Ionis Pharmaceuticals Q3 2026: Net Loss Narrows to $110M

Ionis Pharmaceuticals, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting financial results for the three and nine months ended on that date.

Anjali Anand | 09 November 2026

C3is Inc. Completes 1-for-5 Reverse Stock Split Nov. 8

C3is Inc. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing that the company effected a one-for-5 reverse stock split of its common stock, with the split becoming effective at 11:59 p.m. Eastern time on November 8, …

Anjali Anand | 09 November 2026

Vistagen Reports FDA Type C Meeting on Fasedienol SAD Path

Vistagen Therapeutics, Inc. filed a Form 8-K on November 9, 2026, announcing a regulatory update following a Type C meeting with the U.S. Food and Drug Administration to discuss potential registrational paths for its lead product candidate, fasedienol, in social anxiety disorder.

Nitish Kishor | 09 November 2026

Newell Brands Elects William Newlands to Board

Newell Brands Inc. filed a Form 8-K on November 9, 2026, disclosing that its Board of Directors voted on November 4, 2026, to expand the board from eight to nine members and elect William Newlands as a director, effective January 1, 2027.

Nitish Kishor | 09 November 2026

3M 1.500% Notes due 2026 Removed from NYSE Listing

The New York Stock Exchange filed a notification on November 9, 2026, to remove 3M Co's 1.500% Notes due 2026 from listing and registration under Section 12(b) of the Securities Exchange Act of 1934.

Vinay Lochav | 09 November 2026

Waste Management CIO Varkey Johnson Sells 500 Shares at $242

Johnson Varkey, SVP and Chief Information Officer of Waste Management Inc, filed a Form 4 on November 6, 2026, disclosing the sale of 500 shares of common stock on November 5, 2026.

Shwetambri Chauhan | 09 November 2026

Aqeel Ahmad Fatmi Files Form 3 as New Elite Pharma Director

Aqeel Ahmad Fatmi filed an initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing his status as a newly reporting director of Elite Pharmaceuticals Inc /NV/ following a triggering event dated October 28, 2026.

Manish Choudhary | 09 November 2026

Alarum Technologies Updates AGM Proxy Materials for Dec. 30 Meeting

Alarum Technologies Ltd. filed a Form 6-K on November 9, 2026, furnishing updated proxy materials for its Annual General Meeting of Shareholders scheduled for December 30, 2026, superseding materials originally furnished on November 5, 2026.

Anjali Anand | 09 November 2026

Bitmine Reports $14.3B Holdings With 6.07M ETH

Bitmine Immersion Technologies, Inc. filed a press release on November 9, 2026, announcing its crypto, cash, and marketable securities holdings totaling $14.3 billion as of November 8, 2026.

Manish Choudhary | 09 November 2026

Tonix Pharma Posts $134M Nine-Month Net Loss in Q3 2026

Tonix Pharmaceuticals Holding Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting accelerating operating losses alongside significant growth in product revenue.

Aakashdeep | 09 November 2026
Support

Hi! How can we help you today?

Loading…